CNR1 and cancer: We have discovered that synthetic CB1 cannabinoids, specifically AM-404, arvanil, and olvanil, can surreptitiously orchestrate tunneling nanotubes, enhance cell viability, and promote scratch wound migration and epithelial–mesenchymal transition (EMT) in pancreatic PANC-1 and colorectal SW-620 cancer cells.